Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy

This study has been completed.
Sponsor:
Information provided by:
Vasogen
ClinicalTrials.gov Identifier:
NCT00111969
First received: May 26, 2005
Last updated: June 28, 2006
Last verified: June 2006